This message contains images. If you don't see images, click here to view.
Advertise in this news brief.
|
|
| |
Advertisement
Effect of chemotherapy on surgical resection of liver tumors
Medical Xpress
A study of pediatric patients with hepatoblastoma led by researchers at Children's Hospital Los Angeles (CHLA) suggests an opportunity to reduce chemotherapy in up to 65 percent of patients, which could lead to a decrease in the incidence of adverse effects. Their findings were recently published online in the British Journal of Surgery.
|
|
Share this article:
    |
|
|
Advertisement
Factors contributing to pancreatic cancer identified
Oncology Nurse Advisor
New research that provides a better understanding of pancreatic cancer may help identify those people at increased risk.
Pancreatic cancer is a stealthy cancer that is usually detected at very late stages and has a 5-year survival rate of less than five percent. Strategies that might help identify which persons have an increased risk of developing the disease are sorely needed. Some cases seem to run in families, but the genes that are responsible for such inherited predisposition remain largely unknown.
Advertisement
Annual NCDB Call for Data
Commission on Cancer
The Commission on Cancer (CoC) is committed to assisting accredited cancer programs with maintaining the highest level of data quality possible. We appreciate your facility's participation and contribution to the National Cancer Data Base (NCDB). Data submissions are essential for assessing and improving the quality of cancer patient care. The information generated from the NCDB enables cancer programs to compare treatment and outcomes with regional, state, and national patterns.
This year, the Annual NCDB Call for Data submissions are scheduled during January 2015, and corrections are due by April 1, 2015. A general overview is provided. Please see https://www.facs.org/quality-programs/cancer/ncdb/datasub/registrar for specific details.
Advertisement
PRODUCT SHOWCASE
Postoperative radiation therapy improves overall survival in NSCLC patients
OncLive
Patients with non–small-cell lung cancer (NSCLC) who received postoperative radiation therapy (PORT) lived four months longer on average than patients who did not receive radiation but who had the same disease site, tumor histology, and treatment criteria, according to a large retrospective study. Limited data indicate that PORT may be beneficial for patients with involved N2 nodes.
Implementing Survivor Care Plans in CoC-accredited Cancer Programs
Commission on Cancer/American Cancer Society
Join us for a free webinar on Nov. 11 from 1:00 p.m. to 2:30 p.m. EST. Speakers from the Commission on Cancer, CoC-accredited hospitals, and the American Cancer Society will discuss the recent clarifications to Standard 3.3 and share their perspectives on implementing survivor care plans within CoC-accredited cancer programs.
Early prostate cancer postoperation PSA values useful
Renal & Urology News
Early PSA measurements following radical prostatectomy (RP) may aid in risk stratification of men with positive surgical margins and perhaps spare patients who are unlikely to experience disease progression the toxicity associated with immediate adjuvant radiotherapy, according to a new study.
Stepan Vesely, MD, and colleagues at the Charles University 2nd Faculty of Medicine University Hospital in Prague, Czech Republic, studied 116 patients found to have positive surgical margins (PSM) after RP for localized prostate cancer (PCa).
2012 data available in NCDB reporting tools
Commission on Cancer
The NCDB reporting tools were recently released with updates to include 2012 annual cases and updates submitted by CoC-accredited cancer programs earlier this year. The biggest change users will see are the addition of 2012 cases to the Hospital Comparison Benchmark Reports and the Cancer Program Practice Profile Reports (CP3R). Additional quality measures were also released in gastric and non-small cell lung cancerFor further information, contact NCDB at ncdb@facs.org
.
Imaging techniques for treatment evaluation for metastatic breast cancer
AHRQ
In spite of significant gains in detection and treatment, breast cancer continues to have a
broad impact in the United States. An estimated 234,580 individuals received new diagnoses in
2013. About 33 percent of individuals with breast cancer diagnosed between 2001 and 2007 had
regional metastases, with a five-year relative survival rate of 84 percent. Approximately 5 percent
were diagnosed with distant metastases, most commonly to the bones, lungs, liver, or brain, and
had a five-year relative survival rate of only 23 percent.
Pursuing Excellence through NAPBC Accreditation: Register now
NAPBC
Whether you are preparing for a re-accreditation survey, first survey, or looking for information
on the National Accreditation Program for Breast Centers (NAPBC), this education program gives you the information you need. Avoid the fee increase; register today.Pursuing Excellence through NAPBC Accreditation is the only education program developed
and taught by NAPBC staff, board members, and surveyors. This program prepares your breast
center for survey and helps staff not familiar with the NAPBC standards understand their role in
the accreditation process.
Researchers develop the first cancer health literacy tool
Medical Xpress
Virginia Commonwealth University (VCU) Massey Cancer Center researchers have developed the first and only tool that can accurately measure cancer health literacy (CHL) and quickly identify patients with limited CHL. This tool has the potential to improve communication and understanding between physicians and patients, which, in turn, could lead to better clinical outcomes.
Missed last week's issue? See which articles your colleagues read most.
Clinical practice guidelines address multimodality treatment for esophageal cancer
Medical Xpress
The Society of Thoracic Surgeons (STS) has released new clinical practice guidelines for treating cancer of the esophagus and gastroesophageal junction (the area where the esophagus meets the stomach). The guidelines, published in the November 2014 issue of The Annals of Thoracic Surgery, include nine evidence-based recommendations that address issues related to multimodality care, including neoadjuvant therapy (chemotherapy and radiation therapy given prior to surgery). The goal of this therapy is to reduce the extent of cancer before an operation to maximize the chance of obtaining a cure.
Imaging techniques for the diagnosis and staging of hepatocellular carcinoma
AHRQ
Hepatocellular carcinoma (HCC) is the most common primary malignant neoplasm
of the liver, and accurate diagnosis and staging of HCC are important for guiding treatment and
other clinical decisions. A number of imaging modalities are available for detection of HCC in
surveillance and nonsurveillance settings, evaluation of focal liver lesions to identify HCC, and
staging of HCC. The purpose of this review is to compare the effectiveness of imaging
techniques for HCC on test performance, clinical decisionmaking, clinical outcomes, and harms.
Two experts discuss mammography issues on The Recovery Room Show
NAPBC
The Recovery Room Show recently launched a new episode discussing the benefits and controversies surrounding mammographic screening. In the episode, host Frederick L. Greene, MD, FACS, a surgical oncologist from Charlotte, N.C., and a member of the Commission on Cancer since 2000, talks with two leading experts in the field. The show includes a discussion on common concerns with mammography, the role of insurance companies, MRIs, and a high-profile recent Canadian study that cast doubt on the abilities of the screening tool.
|
|
|
Advertisement
|
|
|
The CoC Brief
Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit
Samantha Emerson, Content Editor, 469.420.2669
Contribute news
Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.
Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.
This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!
|
|
Recent issues
Oct. 29, 2014
Oct. 29, 2014
Oct. 22, 2014
Oct. 8, 2014
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
